Middle East & North Africa | Antiretroviral therapy coverage (% of people living with HIV)

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy. Limitations and exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information. Statistical concept and methodology: Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. Antiretroviral therapy has led to huge reductions in death and suffering of people with advanced HIV infection.
Publisher
The World Bank
Origin
Middle East & North Africa
Records
63
Source
Middle East & North Africa | Antiretroviral therapy coverage (% of people living with HIV)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000 0.95208333
2001 1.19495213
2002 1.24111374
2003 2.29756326
2004 2.54235399
2005 3.15729209
2006 4.47017673
2007 5.07958478
2008 6.07392364
2009 7.63041765
2010 9.1676876
2011 11.30484245
2012 14.21928919
2013 16.94623265
2014 20.47926201
2015 24.86959628
2016 30.07796185
2017 34.37845863
2018 39.5468202
2019 42.63005929
2020 44.93857941
2021 47.53783306
2022

Middle East & North Africa | Antiretroviral therapy coverage (% of people living with HIV)

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy. Limitations and exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information. Statistical concept and methodology: Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. Antiretroviral therapy has led to huge reductions in death and suffering of people with advanced HIV infection.
Publisher
The World Bank
Origin
Middle East & North Africa
Records
63
Source